These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3151321)

  • 1. [Pseudomonas aeruginosa burn wound infection in rats].
    Guo ZR
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1988 Mar; 4(1):51-3. PubMed ID: 3151321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 3. Local Application of Probiotic Bacteria Prophylaxes against Sepsis and Death Resulting from Burn Wound Infection.
    Argenta A; Satish L; Gallo P; Liu F; Kathju S
    PLoS One; 2016; 11(10):e0165294. PubMed ID: 27780258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemilogy of Pseudomonas in a burn intensive care unit.
    MacMillar BG; Edmonds P; Hummel RP; Maley MP
    J Trauma; 1973 Jul; 13(7):627-38. PubMed ID: 4197546
    [No Abstract]   [Full Text] [Related]  

  • 5. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyocyanic sepsis in burn disease].
    Baliabin AA; Krasnopevtseva OS; Pinchuk VM
    Arkh Patol; 1972; 34(11):31-7. PubMed ID: 4630397
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of surface swab cultures and quantitative tissue biopsy cultures to predict sepsis in burn patients: a prospective study.
    Sjöberg T; Mzezewa S; Jönsson K; Robertson V; Salemark L
    J Burn Care Rehabil; 2003; 24(6):365-70. PubMed ID: 14610420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 9. The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
    Barnea Y; Carmeli Y; Kuzmenko B; Gur E; Hammer-Munz O; Navon-Venezia S
    Ann Plast Surg; 2006 Jun; 56(6):674-9. PubMed ID: 16721084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility to infection related to extent of burn injury.
    Yurt RW; McManus AT; Mason AD; Pruitt BA
    Arch Surg; 1984 Feb; 119(2):183-8. PubMed ID: 6421264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.
    Van Rooyen CE; Ross JF; Bethune GW; MacDonald AC
    Can Med Assoc J; 1967 Nov; 97(20):1227-9. PubMed ID: 4964146
    [No Abstract]   [Full Text] [Related]  

  • 12. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
    Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
    J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
    Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
    Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa infection in burn patients].
    Orlov AN
    Khirurgiia (Mosk); 1979 Aug; (8):7-10. PubMed ID: 502283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Pseudomonas aeruginosa septicemia in burns].
    Wang DW
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep; 3(3):181-3, 237-8. PubMed ID: 3151607
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
    Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
    Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial transmission of carbapenem-resistant Pseudomonas aeruginosa among burn patients.
    Maillet M; Pelloux I; Forli A; Vancoetsem K; Cheong Sing JS; Marfaing S; Ducki S; Batailler P; Mallaret MR
    Infect Control Hosp Epidemiol; 2014 May; 35(5):597-9. PubMed ID: 24709737
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudomonas aeruginosa infections in burn patients (experimental pyocyanaceous bacillus bacteremia in rats)].
    Jacques L; Monsaingeon A
    Bull Inst Natl Sante Rech Med; 1967; 22(1):5-32. PubMed ID: 6079410
    [No Abstract]   [Full Text] [Related]  

  • 20. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.